Independent minds. Global perspective. A publication for the builders
Biotechnology / Sacramento, CA

Karthik Raman.

Co-founder
Persist AI

Karthik Raman co-founded Persist AI, which develops automation for long-acting drug formulations. His public biography connects the venture to observing the burden of infusion treatment. Persist combines robotics, experimental data, and predictive models to investigate how drugs can be packaged into injectable delivery structures.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Karthik Raman and the story of Persist AI.

Persist's public launch describes a closed loop in which robotic experiments generate formulation data that informs subsequent predictions and experiments. The team focuses on microsphere-based drug delivery rather than developing an unrelated new therapeutic molecule. Its founder account supplies a personal motivation for that work. The supplied evidence establishes the research process without independently validating development speed, reduced treatment burden, or the safety and effectiveness of any formulation.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Persist AI — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗